Wave Life Sciences Ltd.
NASDAQ:WVE
5.86 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Wave Life Sciences Ltd. |
Symbool | WVE |
Munteenheid | USD |
Prijs | 5.86 |
Beurswaarde | 730,964,680 |
Dividendpercentage | 0% |
52-weken bereik | 3.5 - 7.67 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Paul B. Bolno M.B.A., M.D., MBA |
Website | https://www.wavelifesciences.com |
An error occurred while fetching data.
Over Wave Life Sciences Ltd.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)